Accuray wins CyberKnife contract with Montecito Medical

TriMed Staff | | Health Imaging | Practice Management
Montecito Medical Ventures (MMV), a joint venture of Montecito Medical Investment Company, has formed an alliance by purchasing two placement contracts from Accuray, manufacturer of the CyberKnife radiosurgery system.

The purchase has created a program that gives healthcare providers that are affiliated with Montecito Medical access to medical technologies through its financing program. MMV will make a pool of investment capital for healthcare transactions available to providers interested in acquiring CyberKnife or other advanced medical technologies.

Using image guidance technology and computer controlled robotics, the CyberKnife System is designed to track the tumor, detect its location and make needed adjustments throughout the procedure, according to the Sunnyvale, Calif.-based Accuray.

TriMed Staff

Related Content

Warning: Sidelined reactor could trigger medical isotope shortage
Malpractice watchers: Radiologists, imaging societies should bone up on the ‘science of visual perception’
ACR shares guidance for radiology providers facing IV supply shortages after hurricane
Incidental finding characteristics that warrant communication
AI implementation improves when radiology staff concerns are considered
Hospital organization sees impressive returns from POCUS integration

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup